Patent · US Active

Chimeric influenza vaccines

US11918641B2 · kind B2 · utility

6Cited by

3References

14Claims

0Family size

Assignee

ACADEMIA SINICA · TW

Inventors

Chi-Huey Wong · Village of La Jolla, US
Hsin-Yu LIAO · Fangshankeng, TW
Shih-Chi Wang · Taipei, TW
Yi-An KO · Taipei, TW
Kuo-I Lin · Taipei, TW
Che Ma · Taipei, TW
Ting-Jen Cheng · New Taipei, TW

Key dates

Filing date	May 7, 2021
Grant date	Mar 5, 2024
Priority date	—
Expiry date	May 7, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16171
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to a chimeric influenza virus hemagglutinin (HA) polypeptide, comprising one or more stem domain sequence, each having at least 60% homology with a stem domain consensus sequence of H1 subtype HA (H1 HA) and/or H5 subtype HA (H5 HA), fused with one or more globular head domain sequence, each having at least 60% homology with a globular head domain consensus sequence of H1 subtype HA (H1 HA) or H5 subtype HA (H5 HA).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.